Cognitive Outcomes During Adjunctive Cenobamate Treatment in Patients with Drug-Resistant Epilepsy: An Interim Analysis of a Prospective Observational Study
Authors:
- Hanna LjungHLHanna Ljung
- Petrea FridPFPetrea Frid
- Arne ReimersARArne Reimers
- Anders BlomgrenABAnders Blomgren
- Maria Compagno StrandbergMSMaria Compagno Strandberg
Open Access
- 1 October 2026
- journal article
- Published by Elsevier in Epilepsy & Behavior
- Vol. 185
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Real‐world effectiveness of cenobamate in drug‐resistant and ultra‐refractory epilepsy: A multicenter studyEpilepsia Open, 2026
- The Effects of Cenobamate and Its Dosage on Cognition: A Retrospective Longitudinal Study in 84 Individuals with EpilepsyCNS Drugs, 2025
- Effect of Cenobamate on Cognition in Patients with Drug-Resistant Epilepsy with Focal Onset Seizures: An Exploratory StudyCNS Drugs, 2024
- Prospective study of cenobamate on cognition, affectivity, and quality of life in focal epilepsyEpilepsia Open, 2023
- Effects of cenobamate on cognitive performance of epilepsy patientsSeizure: European Journal of Epilepsy, 2022
- Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug–Drug Interactions and TolerabilityCNS Drugs, 2021
- Mass Balance, Metabolism, and Excretion of Cenobamate, a New Antiepileptic Drug, After a Single Oral Administration in Healthy Male SubjectsEuropean Journal of Drug Metabolism and Pharmacokinetics, 2020
- Adverse cognitive effects of antiepileptic pharmacotherapy: Each additional drug mattersEuropean Neuropsychopharmacology, 2015
- Neuropsychological and Behavioral Effects of Antiepilepsy DrugsNeuropsychology Review, 2007
- A comparison of methods for measuring cognitive change in older adultsArchives of Clinical Neuropsychology, 2005